CD19 and myeloid sarcoma: In terms of which types of B cells enter the CNS during MS, the majority exhibit a memory phenotype (CD19+CD27+CD138−), and in this location, an oligoclonal B cell repertoire has been observed that may be linked to the specificities of the intrathecal IgGs that are observed in the CSF during MS [18]–[22].